Navigation Links
Current and Emerging Drugs Continue to Struggle for Patient Share in the Treatment of Major Depressive Disorder
Date:7/15/2008

omise, most of them earned inferior scores in efficacy, safety and tolerability, and/or delivery features when compared with escitalopram."

About the Report

Major Depressive Disorder: Long-Term Efficacy Would Differentiate a New Drug in the Crowded Antidepressant Market is a DecisionBase 2008 report from Decision Resources. DecisionBase 2008 combines market forecasts with clinical and commercial end points to assess market share projections in 35 indications. These outputs are driven by quantitative and qualitative primary research. DecisionBase 2008 provides detailed market share, patient share, and price-per-day projections for emerging drugs in development. The market share projections are based on prescriber surveys that compare physicians' expectations of a potential target product profile with an emerging product profile of the leading drugs in development.

The report can be purchased by contacting Decision Resources. Members of the media may request an interview with an analyst.

About Decision Resources

Decision Resources (http://www.decisionresources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Elizabeth Marshall

Decision Resources

781-296-2563

emarshall@dresources.com


'/>"/>
SOURCE Decision Resources
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Current Concepts in Clostridium difficile Infection: A Focus on Recurrent Disease
2. Leading Academic Institutions Collaborate on 800-Patient Study of Effectiveness of Cryoablation for Men With Recurrent Prostate Cancer
3. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
4. Current and Emerging Drugs Have No Advantage Over Enbrel in Inhibiting/Slowing the Progression of Rheumatoid Arthritis
5. CV Therapeutics Anti-Ischemic Therapy Ranexa(R) Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN-TIMI 36 Patients With Angina
6. Jazz Pharmaceuticals, Inc. Announces Receipt of FDA Orphan Drug Designation for Recurrent Acute Repetitive Seizures Product Candidate
7. Enrollment of Women in Cardiovascular Trials Fails to Meet Current Federal Mandates
8. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
9. Malaria Vaccine Developer Sanaria Inc. Receives the Technology Council of Marylands Emerging Company of the Year Award
10. Revolution Health and EmergingMed Launch Cancer Clinical Trial Matching and Referral Service
11. Bionovo Discovers New Estrogen Regulatory Elements for Breast Cancer and Osteoporosis Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... MADRID , June 2, 2015 ... annuale della American Society of Clinical Oncology    ... di fase 3 SAR3007, resi noti dal dipartimento Ricerca ... evidenziato un significativo miglioramento della sopravvivenza libera da progressione ... rispetto al trattamento con dacarbazina in pazienti con liposarcoma ...
(Date:6/1/2015)... , June 1, 2015  LaunchPad Medical, ... a definitive agreement to license Stryker Corporation,s (NYSE: ... based on a unique synthetic biomaterial.  Under the ... exclusive worldwide license from Stryker for this technology ... pending U.S. patents and includes data from multiple ...
(Date:6/1/2015)... , June 1, 2015  Research Solutions, Inc. (OTCQB: ... and medical (STM) information for life science companies, academic ... to present at the LD Micro Invitational being held ... in Los Angeles . ... on Wednesday, June 3rd at 9:30 a.m. Pacific time, ...
Breaking Medicine Technology:PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 2PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 3PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 4PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 5PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 6LaunchPad Medical Executes Definitive License Agreement with Stryker for Novel Bone Adhesive Technology 2Research Solutions to Present at the LD Micro Invitational on June 3, 2015 2Research Solutions to Present at the LD Micro Invitational on June 3, 2015 3
... LLC has launched a full line of non-prescription, topical ... relief of nerve pain caused by diabetes, post-shingles, chemotherapy, ... the only full line of skin care and pain ... developed from the ground up in oils, lotions and ...
... cites in its newly published " Medical Imaging ... medical imaging equipment exceeded $21 billion in ... Medical imaging can ... computed tomography (CT), positron emission tomography (PET), single ...
Cached Medicine Technology:Affordable Nerve Pain Treatment Now Available in the U.S. 2Global Spending on Medical Imaging Equipment Exceeded $21 Billion in 2010 2Global Spending on Medical Imaging Equipment Exceeded $21 Billion in 2010 3
(Date:6/2/2015)... TheCelebrityDresses.com, a popular online store selling ... their summer fashion cocktail dresses. The company carries more ... would be suitable for a wide variety of summer ... designs and make high quality trendy special occasion ... high quality satin, chiffon and cotton. Their products feature ...
(Date:6/2/2015)... 2015 First Choice Emergency Room ... in the United States, named Kenneth Alan Totz, D.O.as ... Road facility. , “We are pleased to announce ... facility,” said Dr. James M. Muzzarelli, Executive Medical Director ... received his undergraduate degree from St. Edwards University in ...
(Date:6/2/2015)... Thermi, formerly ThermiAesthetics, a fast ... transitioned into its new company headquarters in Irving, ... continued rapid worldwide expansion and houses the corporate ... Thermi employees, including those of the warehousing, shipping ... one of the fastest growing aesthetic companies in ...
(Date:6/2/2015)... Join us for a new event in Westwood, ... Rhonda Martin , who overcame her brain aneurysm during the ... to raising awareness and funds for brain aneurysm research. ... that there will be one less case of someone suffering ... to join the 1st Anniversary Awareness Walk in Honor ...
(Date:6/1/2015)... City, NY (PRWEB) June 02, 2015 ... honors Miriam Wirski as a 2015-2016 inductee ... is recognized with this prestigious distinction for leadership in ... for professional women, boasting more than 700,000 members and ... present Miriam with this prestigious honor,” said NAPW President ...
Breaking Medicine News(10 mins):Health News:First Choice Emergency Room Announces Dr. Kenneth Alan Totz as New Medical Director of Houston – Jones Road Facility 2Health News:Thermi Moves to New Corporate Headquarters as Rapid Company Expansion Continues 2Health News:New Awareness Raising Event in Westwood, NJ to Benefit Renowned Brain Aneurysm Foundation 2Health News:National Association of Professional Women Inducts Miriam Wirski, Holistic Life Coach, Into its VIP Woman of the Year Circle 2
... Reporter , TUESDAY, July 13 (HealthDay News) -- Patients ... symptoms frequently attributed to memory problems or difficulty finding ... brain disorder may also have a reduced ability to ... from the University of Florida and other institutions showed ...
... content (BMC) as they age than men who are free ... of BJUI . The findings are important because loss ... of fragile bones, fractures and osteoporosis. American researchers studied ... average age of 56 between 1973 and 1984. The maximum ...
... HealthDay Reporter , MONDAY, July 12 (HealthDay News) -- ... open blocked arteries are getting proven treatments in U.S. hospitals ... results of a large-scale study. Data on more than ... January 2007 through June 2009 also showed that the patients ...
... The future health of offspring is more negatively impacted ... nursing compared with high-fat diet consumption during pregnancy, according ... new research results are being presented at the Annual ... Behavior (SSIB), the foremost society for research into all ...
... aggressive infection control measures allowed a Dallas hospital ... type of bacteria that has become increasingly prevalent ... antibiotics. The findings were presented today at the ... Association for Professionals in Infection Control and Epidemiology ...
... Society of America (GSA) the nation,s largest ... has chosen Linda George, PhD, of Duke University as ... Gerontology Award. This distinguished honor is given annually ... about a new synthesis and perspective or have yielded ...
Cached Medicine News:Health News:Emotions May Be Blunted in Alzheimer's Patients 2Health News:Emotions May Be Blunted in Alzheimer's Patients 3Health News:High-risk prostate cancer associated with significantly lower bone mineral content loss 2Health News:Heart Attack Care Is Getting Better, Report Finds 2Health News:Heart Attack Care Is Getting Better, Report Finds 3Health News:Prompt actions halt alarming infection outbreak at Dallas hospital 2Health News:Prompt actions halt alarming infection outbreak at Dallas hospital 3
...
...
...
Open blade speculum designed for both temporal and superior approach ocular surgery. Thumb screw adjusting mechanism. Manufactured in titanium....
Medicine Products: